Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2023-12-29 00:00:00 ET · period of report 2023-12-28 · accession 0001415889-23-017015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-29 | 2023-12-28 | FENC | Raykov Rosty | CEO, Dir | M - OptEx | $1.59 | +8,540 | 291.1K | +3% | +$13.6K |
| D | 2023-12-29 | 2023-12-28 | FENC | Raykov Rosty | CEO, Dir | S - Sale+OE | $11.55 | -3,656 | 287.5K | -1% | -$42.2K |
| D | 2023-12-29 | 2023-12-28 | FENC | Raykov Rosty | CEO, Dir | M - OptEx | $1.59 | +8,540 | 271.8K | +3% | +$13.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2023-12-28 | M | A | 8,540 | $1.59 | 291,127 | D | — | — | (F1) Shares acquired through the exercise of an option contract with strike price of $1.59 and an expiration date of January 24, 2024. |
| 2 | Common | Common shares | 2023-12-28 | S | D | 3,656 | $11.55 | 287,471 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 3 | Derivative | Commons Shares | 2023-12-28 | M | A | 8,540 | $1.59 | 271,784 | D | $1.59 · 2014-01-24 to 2024-01-24 | 8,540 options | (F3) Represents options granted on January 24, 2014, with a strike price of $1.59 and an expiration date of January 24, 2024. |